Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-25 @ 5:03 AM
NCT ID: NCT04241718
Eligibility Criteria: Inclusion Criteria: 1. Age 18 years or older 2. Subject or legally authorized representative is able to provide appropriate consent to participate 3. Hospitalized for ADHF with fluid overload as indicated by at least two of the following: 1. Pitting edema ≥ 2+ of the lower extremities 2. Jugular venous distention \> 8 cm 3. Pulmonary edema/pleural effusion on chest x-ray 4. Paroxysmal nocturnal dyspnea or ≥ two- pillow orthopnea 5. Respiration rate ≥ 20 per minute Exclusion Criteria: 1. Unable or unwillingness to provide informed consent or to comply with study requirements 2. Subject who is pregnant 3. Acute coronary syndrome 4. Known bilateral renal artery stenosis 5. Serum creatinine \> 3.0 mg/dL at the time of presentation 6. Subject receiving ongoing active treatment with diuretics (up to 2 doses of IV diuretics are permitted before initiation of ultrafiltration therapy) 7. Systolic blood pressure ≤ 90 mmHg 8. Poor or unattainable central access 9. Has bleeding disorder 10. Contraindications to systemic anticoagulation 11. Allergic to iodine, albumin, or iodinated I-131 albumin 12. Active myocarditis or hypertrophic obstructive cardiomyopathy 13. Severe uncorrected valvular stenosis 14. Complex congenital heart disease 15. Systemic infection 16. Previous organ transplant 17. Enrollment in other clinical trials 18. Life expectancy ≤ 6 months
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT04241718
Study Brief:
Protocol Section: NCT04241718